posting velocity //
Opens vs closes per day
Based on 4 events over 3 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
טוען…
Back to companies
01 02
Johnson & Johnson
Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.
Showing: Israel. Click another pill to switch.
Open now
0
Total active openings across all sites
Δ 28-day
0
Opens minus closes in the last 28 days
Δ 90-day
0
Opens minus closes in the last 90 days
role mix //
Role mix — current vs baseline
Active nowBaseline 90d
- Product0.0%(-100.0)0
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Seniority pyramid
Seniority is not exposed by the source for this company.
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
Geographic split
—
Active openings by region. Click a row to see jobs in that area.
time on market //
How long a job stays open
Median
0.1 days
25th pct
0.1 days
75th pct
0.9 days
Based on 2 closed jobs and 0 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.Low event count — the median will stabilise after ~48 more closures. Until then treat the values as indicative.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
—
Fewer than 10 closures in the window — not enough to compute.
company intel · ai-generated
Company intel & deep analysis
Updated 1d ago
- M&A
- Product
Snapshot
Johnson & Johnson MedTech is the medical devices and technology division of Johnson & Johnson (NYSE: JNJ). Globally headquartered in New Brunswick, New Jersey, the division's Israeli tech operations are largely built upon strategic acquisitions. The foundation of its local presence is Biosense Webster, founded in Israel in 1993 by Shlomo Ben-Haim and acquired by J&J in 1997 for approximately $400 million. The single biggest event affecting its Israeli operations in the past 12 months was the late 2024 acquisition of Caesarea-based cardiovascular company V-Wave for $600 million upfront and up to $1.1 billion in clinical and commercial milestones.
Core Activity
The division develops hardware and software for surgery, orthopedics, vision, and interventional solutions. The Israeli R&D centers focus heavily on electrophysiology and cardiovascular disease. Biosense Webster engineers the CARTO 3 System, a 3D cardiac mapping platform used by electrophysiologists to diagnose and treat cardiac arrhythmias, specifically atrial fibrillation. The local technical teams work on algorithms, signal processing, embedded software, and clinical data analysis to track catheters inside the heart in real-time.
key people & leadership
Key people & leadership
2 key people, sourced from public records — with a per-row confidence score.
T
Tim Schmid
Executive Vice President and Worldwide Chairman, J&J MedTech
Schmid leads the global MedTech division, responsible for the interventional, orthopedic, surgery, and vision businesses.
🟢Verified
Verified 1d ago
leadership
J
Joaquin Duato
Chairman & CEO, Johnson & Johnson
🟢Verified
Verified 1d ago